Sun Pharma's focus on specialty drugs pays off https://ift.tt/jgFQTqn company's revenues grew 11% driven by strong growth posted by the India business and the global specialty sales in the US. A third of the company's revenues is earned each from India and the US. Sun's market share in India increased from 8.3% to 8.4% for the year ended September 2023.
Wednesday, November 1, 2023
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment